CytRx News
Most Popular CytRx Story
ASH roundup: Ariad, Cephalon and Novartis make a splash
There's plenty of news spilling out of the ASH meeting today. Here's a roundup of the highlights.
Ariad Pharmaceuticals made a splash, says TheStreet, with promising early-stage data from AP24534, Read more...
Latest Headlines
- December 8, 2009
- December 2, 2009
- October 15, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
